Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ciana, I. Toller, M. Guerra, B. Bembi, M. Canciani (Udine, Italy). Pulmonary function and exercise tolerance in glycogenosis type II (GSDII). Eur Respir J 2011; 38: Suppl. 55, 924

Member's Comments

No comment yet.

Related content which might interest you: Restrictive lung disfunction in metabolic syndrome and type II diabetes Source: Eur Respir J 2006; 28: Suppl. 50, 73s Year: 2006 Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease Source: Eur Respir J 2005; 26: 1024-1031 Year: 2005 Type II pneumocyte transplantation in ARDS Source: International Congress 2016 – Cell therapy for ARDS and sepsis Year: 2016 Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Mucopolysaccharidosis type VI: Assessment of functionality, functional capacity and respiratory muscle strength Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions Year: 2015 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Altered exercise capacity in children with type 1 diabetes Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness Year: 2021 Pulmonary function tests in type 2 diabetes: a meta-analysis Source: ERJ Open Res, 7 (1) 00371-2020; 10.1183/23120541.00371-2020 Year: 2021 Respiratory function in stage II pulmonary sarcoidosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 385s Year: 2001 Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene Source: Eur Respir J 2002; 19: 195-198 Year: 2002 Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015 Longitudinal bronchoscopy findings in children with mucopolysaccharidosis II (MPS II) Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Pulmonary hypertension associated with neurofibromatosis type 1 Source: Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 Year: 2018 Sleep in type II diabetes Source: Annual Congress 2003 - Cough and sleep disorders Year: 2003 Pulmonary hypertension in patients with neurofibromatosis type I Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 HLA class II alleles are associated with development of emphysema in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Lung function in children with juvenile diabetes type 1 Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002 Exercise tolerance and ventilatory response in patients with type-1 diabetes Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Serum type III procollagen peptide in idiopathic pulmonary fibrosis: peptide levels and anti-fibrosis therapy Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005